Information provided in the product description is from published literature. Due to the nature of scientific experimentation, your results (e.g., selectivity and effective concentrations) or specific application for this product may differ. If you have questions about how this product fits your application, please contact our technical support staff.
Visit our FAQ
Toll Free Phone (USA and Canada Only): (888) 526-5351
Direct Phone: (734) 975-3888
Provide batch numbers separated by commas to download or request available product inserts, QC sheets, certificates of analysis, data packs, and GC-MS data.
Darodipine is a calcium channel inhibitor.1 It selectively inhibits calcium-induced contractions of isolated rabbit aorta (pD2 = 8.8) over norepinephrine-, serotonin-, or angiotensin II-induced contractions at 10 µM. In vivo, continuous infusion of darodipine (2 µg/kg per minute) increases cerebral tissue oxygenation in a cat model of focal ischemia induced by cerebral artery occlusion (CAO).2 Darodipine (5 mg/kg) reduces mean arterial blood pressure and increases arterial luminal area in spontaneously hypertensive rats (SHRs).3
WARNING This product is not for human or veterinary use.
1. PY 108-
2. Calcium antagonist PY 108-
3. Influence of treatment with the calcium channel blocker darodipine (PY 108-